Scarica l'app Stockscreener
26.74
0.75%
0.20
Dopo l'orario di chiusura:
27.09
0.35
+1.31%
Precedente Chiudi:
$26.54
Aprire:
$26.74
Volume 24 ore:
158.69K
Relative Volume:
0.30
Capitalizzazione di mercato:
$370.47M
Reddito:
-
Utile/perdita netta:
$-19.48M
Rapporto P/E:
-18.26
EPS:
-1.4641
Flusso di cassa netto:
$-8.59M
1 W Prestazione:
+15.81%
1M Prestazione:
-0.41%
6M Prestazione:
+138.11%
1 anno Prestazione:
+126.99%
Intervallo 1D:
$26.07
$28.10
Intervallo di 1 settimana:
$22.59
$28.28
Portata 52W:
$7.78
$34.10
Greenwich Lifesciences Inc Stock (GLSI) Company Profile
Nome
Greenwich Lifesciences Inc
Settore
Industria
Telefono
203-434-3290
Indirizzo
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
Compare GLSI vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GLSI
Greenwich Lifesciences Inc
|
26.74 | 370.47M | 0 | -19.48M | -8.59M | -1.4641 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Greenwich Lifesciences Inc Stock (GLSI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-20 | Iniziato | Noble Capital Markets | Outperform |
| 2021-09-01 | Iniziato | H.C. Wainwright | Buy |
Greenwich Lifesciences Inc Borsa (GLSI) Ultime notizie
Big Money Moves: Is Greenwich LifeSciences Inc undervalued by DCF analysisPortfolio Performance Summary & Free Community Supported Trade Ideas - baoquankhu1.vn
Greenwich LifeSciences (NASDAQ:GLSI) Trading Up 11.6%Should You Buy? - MarketBeat
Why (GLSI) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Why did Greenwich LifeSciences stock soar pre-market today? - MSN
ETF Watch: Is Greenwich LifeSciences Inc a turnaround storyWeekly Investment Recap & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Market Review: Is Greenwich LifeSciences Inc a stock for growth or value investorsMarket Activity Summary & High Conviction Buy Zone Alerts - baoquankhu1.vn
GLSI Should I Buy - Intellectia AI
Greenwich LifeSciences reports 33% rise in trial screening rate By Investing.com - Investing.com Canada
Greenwich LifeSciences reports 33% rise in trial screening rate - Investing.com
Greenwich LifeSciences accelerates patient screening in FLAMINGO-01 clinical trial - Traders Union
Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01 - GlobeNewswire
US Stocks Recap: Is Greenwich LifeSciences Inc undervalued by DCF analysisTrade Exit Summary & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Aug Sentiment: Can Greenwich LifeSciences Inc expand into new marketsOptions Play & Long-Term Safe Investment Ideas - baoquankhu1.vn
GLSI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Understanding Momentum Shifts in (GLSI) - Stock Traders Daily
Greenwich LifeSciences abstracts accepted at AACR 2026 meeting By Investing.com - Investing.com Australia
Greenwich LifeSciences abstracts accepted at AACR 2026 meeting - Investing.com Nigeria
Rally Mode: Is BTCM a cyclical or defensive stockWall Street Watch & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Greenwich lands 2 AACR 2026 slots, first with FLAMINGO-01 Steering Committee - Stock Titan
GLSI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Analysis Recap: Is SPRY stock showing strong momentumQuarterly Market Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Short Interest Down 14.7% in January - MarketBeat
How interest rate cuts could boost Greenwich LifeSciences Inc. stockJuly 2025 Macro Moves & Consistent Return Investment Signals - mfd.ru
GLSI PE Ratio & Valuation, Is GLSI Overvalued - Intellectia AI
Avoiding Lag: Real-Time Signals in (GLSI) Movement - Stock Traders Daily
How buybacks impact Greenwich LifeSciences Inc. stock valueWall Street Watch & AI Powered Market Entry Ideas - mfd.ru
Aug Update: Will Greenwich LifeSciences Inc stock benefit from M A2025 Winners & Losers & Community Consensus Trade Signals - baoquankhu1.vn
Is Greenwich LifeSciences Inc. stock trending bullishRate Hike & Smart Money Movement Tracker - mfd.ru
Analyst Upgrade: Is Lavoro Limiteds growth already priced inJuly 2025 Highlights & Low Risk Growth Stock Ideas - baoquankhu1.vn
HC Wainwright Issues Positive Forecast for GLSI Earnings - MarketBeat
Valuation Update: Can Greenwich LifeSciences Inc expand into new marketsJuly 2025 Momentum & Weekly Momentum Stock Picks - baoquankhu1.vn
Greenwich LifeSciences (NASDAQ:GLSI) Stock Price Down 6.7% – Here’s What Happened - Defense World
Greenwich LifeSciences: Strengthened Liquidity and Robust GP2 Data Support Reiterated Buy and $50 Target - TipRanks
Discipline and Rules-Based Execution in GLSI Response - Stock Traders Daily
Patel, Greenwich Lifesciences CEO, buys $63k in GLSI stock By Investing.com - Investing.com Nigeria
Will Greenwich LifeSciences Inc. benefit from current market trendsTrade Signal Summary & Free Real-Time Volume Trigger Notifications - mfd.ru
Greenwich LifeSciences reports $12.5 million cash balance - Investing.com
Greenwich LifeSciences reports $12.5 million cash balance By Investing.com - Investing.com Nigeria
Greenwich LifeSciences provides update on Flamingo-01 cash burn rate and financing strategy - marketscreener.com
Greenwich LifeSciences, Inc. Reports Positive Financial Updates and Progress on FLAMINGO-01 Phase III Trial - Quiver Quantitative
Greenwich Lifesciences Provides Update On Flamingo-01 Cash Burn Rate And Financing Strategy - TradingView
Biotech Greenwich LifeSciences raises $7M in 3 weeks for breast cancer trial - Stock Titan
FDA Approval Boosts Greenwich LifeSciences Stock Sharply - timothysykes.com
Treasury Yields: Will Greenwich LifeSciences Inc benefit from current market trendsMarket Volume Report & Low Risk Entry Point Tips - baoquankhu1.vn
Greenwich: GP2 Vaccine MilestoneWhat FDA Manufacturing Approval Means For Investors - Seeking Alpha
Insiders of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) must be frustrated after market cap dropped US$50m since recent purchases - Yahoo Finance
Behavioral Patterns of GLSI and Institutional Flows - Stock Traders Daily
FDA approves commercial GP2 lot for Greenwich’s breast cancer trial By Investing.com - Investing.com Canada
Why Did Greenwich Lifesciences Stock Soar Pre-Market Today? - Menafn.com
Why Did Greenwich LifeSciences Stock Soar Pre-Market Today? - Asianet Newsable
GLSI Stock Surges Pre-Market On Clearing FDA Manufacturing Step For Its Breast Cancer Trial - Stocktwits
Greenwich Lifesciences Inc Azioni (GLSI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):